Proline oxidase induces apoptosis in tumor cells, and its expression is frequently absent or reduced in renal carcinomas.
Proline oxidase is a p53-induced gene that can mediate apoptosis in lung carcinoma cells. Here, we provide evidence implicating a role for proline oxidase in renal carcinoma. We observed absent or reduced expression of proline oxidase in 8 of 12 primary renal cell carcinomas, with respect to their normal tissue counterparts. Two renal cell carcinomas, which displayed little or no expression of proline oxidase, expressed p53s that were less capable of inducing proline oxidase than p53 isolated from normal renal tissue. One of those tumor-derived p53s contained a double transition mutation at amino acid residues 125 (Ala to Thr) and 193 (Arg to His), and the other exhibited a single transition mutation at amino acid 149 (Ser to Phe). Forced up-regulation of proline oxidase induced the formation of reactive oxygen species and mediated apoptosis in the 786-0 renal cell carcinoma cell line. A proline oxidase antisense vector repressed p53-induced up-regulation of proline oxidase, release of cytochrome c from mitochondria, and apoptosis in 786-0 renal carcinoma cells. Taken together, these findings support a role for proline oxidase as a downstream effector in p53-mediated apoptosis. We hypothesize that its altered expression can contribute to the development of renal carcinomas. The presence of proline oxidase in mitochondria, a primary organelle that regulates apoptosis, places this molecule in a subcellular localization that can directly influence the apoptotic pathway and thus tumorigenesis.
Maxwell
Steve A
SA
Texas A&M University System Health Science Center, Department of Pathology and Laboratory Medicine, College Station, Texas 77843-1114, USA. s-maxwell@tamu.edu
Rivera
Armando
A
D000409:Alanine / Q000737:chemistry; D017209:Apoptosis; D001120:Arginine / Q000737:chemistry; D015153:Blotting, Western; D002277:Carcinoma / Q000201:enzymology* / Q000378:metabolism; D018076:DNA, Complementary / Q000378:metabolism; D005434:Flow Cytometry; D049452:Green Fluorescent Proteins; D006639:Histidine / Q000737:chemistry; D006801:Humans; D007150:Immunohistochemistry; D007668:Kidney / Q000378:metabolism; D007680:Kidney Neoplasms / Q000201:enzymology*; D008164:Luminescent Proteins / Q000378:metabolism; D016376:Oligonucleotides, Antisense / Q000494:pharmacology; D010649:Phenylalanine / Q000737:chemistry; D010957:Plasmids / Q000378:metabolism; D011394:Proline Oxidase / Q000378:metabolism / Q000502:physiology*; D017382:Reactive Oxygen Species; D020133:Reverse Transcriptase Polymerase Chain Reaction; D013912:Threonine / Q000737:chemistry; D014162:Transfection; D014407:Tumor Cells, Cultured; D016159:Tumor Suppressor Protein p53 / Q000378:metabolism; D015854:Up-Regulation
D018076:DNA, Complementary; D008164:Luminescent Proteins; D016376:Oligonucleotides, Antisense; D017382:Reactive Oxygen Species; D016159:Tumor Suppressor Protein p53; D049452:Green Fluorescent Proteins; D013912:Threonine; D010649:Phenylalanine; D006639:Histidine; D001120:Arginine; D011394:Proline Oxidase; D000409:Alanine